🔬 #MeetThePartners: Université de Toulouse & CERPOP!🎓

UT excels in science, health & tech, ranked Top 10 in France & awarded the HR Excellence in Research badge.

Their BIOETHICS team at CERPOP tackles legal, ethical & quality-of-life challenges in #ProjectPICKED.

#Bioethics #PersonalizedMedicine

🌍🔬Rare Disease Day – a day to spotlight rare kidney diseases & the need for better care

At PICKED, we advance personalized medicine in CKD, improving detection, monitoring & treatment.

Let’s raise awareness & drive innovation!💙

#RareDiseaseDay #ProjectPICKED #CKD #Nephrology #PersonalizedMedicine

🚀 New 𝐏𝐈𝐂𝐊𝐄𝐃 publication!

Exploring 𝐜𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐝𝐫𝐮𝐠 𝐫𝐞𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐢𝐧𝐠 to tackle 𝐜𝐚𝐫𝐝𝐢𝐨𝐫𝐞𝐧𝐚𝐥 𝐝𝐢𝐬𝐞𝐚𝐬𝐞—integrating 𝐨𝐦𝐢𝐜𝐬, 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 & 𝐧𝐞𝐭𝐰𝐨𝐫𝐤 𝐦𝐨𝐝𝐞𝐥𝐢𝐧𝐠 to find new therapeutic uses.

📖 Read here: DOI: 10.1002/pmic.202400109

#PrecisionMedicine #DrugRepositioning #Bioinformatics #ProjectPICKED

#MeetThePartners

🔬 𝐔𝐊𝐋-𝐇𝐃 𝐝𝐫𝐢𝐯𝐞𝐬 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐂𝐊𝐃 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡! As a key 𝐏𝐈𝐂𝐊𝐄𝐃 partner, it 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐯𝐞 𝐦𝐨𝐝𝐞𝐥𝐬, 𝐯𝐚𝐥𝐢𝐝𝐚𝐭𝐞𝐬 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬, 𝐚𝐧𝐝 𝐭𝐫𝐚𝐢𝐧𝐬 𝐟𝐮𝐭𝐮𝐫𝐞 𝐞𝐱𝐩𝐞𝐫𝐭𝐬—advancing 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐤𝐢𝐝𝐧𝐞𝐲 𝐜𝐚𝐫𝐞. 🌍💙

#CKD #Nephrology #PICKED #PersonalizedMedicine #UKLHD #ProjectPICKED

GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity - PubMed Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as game-changers across the cardiovascular-kidney-metabolic (CKM) spectrum: overweight/obesity, type 2 diabetes mellitus (T2DM) and a...

🚀 First #PICKED Publication!

Exciting news! New study on GLP-1 RAs in CKD, T2DM, obesity & CVD—game-changers for metabolic & cardiovascular health!

🔗 Read here: pubmed.ncbi.nlm.nih.gov/39583142/

#Nephrology #GLP1RA #CKD #Obesity #T2DM #PersonalizedMedicine #ProjectPICKED